"Nucleoside Deaminases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Catalyze the hydrolysis of nucleosides with the elimination of ammonia.
| Descriptor ID |
D009700
|
| MeSH Number(s) |
D08.811.277.151.486
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleoside Deaminases".
Below are MeSH descriptors whose meaning is more specific than "Nucleoside Deaminases".
This graph shows the total number of publications written about "Nucleoside Deaminases" by people in this website by year, and whether "Nucleoside Deaminases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 5 | 6 |
| 2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nucleoside Deaminases" by people in Profiles.
-
Basic and clinical immunology. J Allergy Clin Immunol. 2003 Mar; 111(3 Suppl):S813-8.
-
Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes. Mol Ther. 2002 Aug; 6(2):287-97.
-
Gene therapy for prostate cancer. Expert Rev Anticancer Ther. 2002 Jun; 2(3):309-21.
-
High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res. 2002 Apr 15; 62(8):2337-42.
-
Current progress in suicide gene therapy for cancer. World J Surg. 2002 Jul; 26(7):783-9.
-
Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther. 2002 Jan 01; 13(1):65-100.
-
Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther. 2002 Jan 01; 13(1):15-63.
-
[Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes]. Zhonghua Gan Zang Bing Za Zhi. 2001 Oct; 9(5):300-2.
-
Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit. Chin Med J (Engl). 2001 Sep; 114(9):972-5.
-
Use of quantitative TaqMan real-time PCR to track the time-dependent distribution of gene transfer vectors in vivo. Mol Ther. 2000 Dec; 2(6):649-56.